Tue, Jul 29, 2014, 6:02 AM EDT - U.S. Markets open in 3 hrs 28 mins

Recent

% | $
Click the to save as a favorite.

Aegerion Pharmaceuticals, Inc. (AEGR) Message Board

  • settoplunge settoplunge Jan 17, 2013 6:18 PM Flag

    Why is This Stock so OverPriced?

    They have one approved orphan drug and nothing else to speak of in the pipeline.

    According to a recent PR:
    They expect revenues of $15M to $25M for 2013 with 250 to 300 patients.
    Next year, assuming EU approval, which is a big if, they expect $100M of revenues and breakeven.

    If approval is granted in the EU they will pursue reimbursement on a country by country basis.
    There are a lot of ifs just to reach breakeven.
    The Company burns cash like an arsonist: $40 million in the past 9 months with no ongoing trials and no marketing expenses.

    It will be difficult to get the EU countries to agree to the Company's outrageous reimbursement requests, IF it's even approved in the EU.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
AEGR
30.07+0.07(+0.23%)Jul 28 3:59 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.